Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Search results from the "OB_Rx" table for query on "021035."

Active Ingredient:	LEVETIRACETAM
Dosage Form;Route:	TABLET; ORAL
Proprietary Name:	KEPPRA
Applicant:	UCB INC
Strength:	250MG
Application Number:	N021035
Product Number:	001
Approval Date:	Nov 30, 1999
Reference Listed Drug	No
RX/OTC/DISCN:	RX
TE Code:	AB
Patent and Exclusivity Info for this product:	View

Active Ingredient:	LEVETIRACETAM
Dosage Form;Route:	TABLET; ORAL
Proprietary Name:	KEPPRA
Applicant:	UCB INC
Strength:	500MG
Application Number:	N021035
Product Number:	002
Approval Date:	Nov 30, 1999
Reference Listed Drug	No
RX/OTC/DISCN:	RX
TE Code:	AB
Patent and Exclusivity Info for this product:	View

Active Ingredient:	LEVETIRACETAM
Dosage Form;Route:	TABLET; ORAL
Proprietary Name:	KEPPRA
Applicant:	UCB INC
Strength:	750MG
Application Number:	N021035
Product Number:	003
Approval Date:	Nov 30, 1999
Reference Listed Drug	No
RX/OTC/DISCN:	RX
TE Code:	AB
Patent and Exclusivity Info for this product:	View

Active Ingredient:	LEVETIRACETAM
Dosage Form;Route:	TABLET; ORAL
Proprietary Name:	KEPPRA
Applicant:	UCB INC
Strength:	1GM
Application Number:	N021035
Product Number:	004
Approval Date:	Jan 6, 2006
Reference Listed Drug	Yes
RX/OTC/DISCN:	RX
TE Code:	AB
Patent and Exclusivity Info for this product:	View

FDA/Center for Drug Evaluation and Research

Office of Generic Drugs

Division of Labeling and Program Support

Update Frequency:

Orange Book Data - Monthly

Generic Drug Product Information & Patent Information - Daily

Orange Book Data Updated Through April, 2013

Patent and Generic Drug Product Data Last Updated: May 17, 2013